Home › Research › Topics › comparative
comparative
5 studies tagged comparative, dated 2019-04-17 to 2025-07-01. Bibliography: BibTeX (.bib) · RIS (.ris)
Newest in this topic
- Equivalence of Plasma and Serum for Clinical Measurement of p-tau217: Comparative Analyses of Four Blood-Based Assays 2025-07-01
- Comparative methods for quantifying plasma biomarkers in Alzheimer's disease: Implications for the next frontier in cerebral amyloid angiopathy diagnostics 2023-10-31
- Comparative Analysis of Alzheimer's Disease Cerebrospinal Fluid Biomarkers Measurement by Multiplex SOMAscan Platform and Immunoassay-Based Approach 2022-01-01
Studies
5 studies carry this tag.
Date range
2019 to 2025
Top journals
- Alzheimer's & dementia : the journal of the Alzheimer's Association 1
- Journal of Alzheimer's disease : JAD 1
- Journal of neurochemistry 1
- Science advances 1
- The journal of prevention of Alzheimer's disease 1
Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.
-
Phosphorylated tau (p-tau) 217 is a promising blood biomarker for Alzheimer's disease (AD).
-
Plasma amyloid beta (Aβ) and tau are emerging as accessible biomarkers for Alzheimer's disease (AD).
-
Our data indicate that SOMAscan performs as well as immunoassay approaches for NfL, Neurogranin, VILIP-1, and sTREM2.
-
Amyloid-β (Aβ) positivity is defined using different biomarkers and different criteria.
-
Detection of amyloid-β (Aβ) aggregates contributes to the diagnosis of Alzheimer disease (AD).